Literature DB >> 4280021

Inhibition of insulin release from the rat pancreas by cyproheptadine and tricyclic antidepressants.

H G Joost, W Poser, U Panten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4280021     DOI： 10.1007/bf00499530

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  6 in total

1.  EFFECTS OF CARBOHYDRATES ON SECRETION OF INSULIN FROM ISOLATED RAT PANCREAS.

Authors:  G M GRODSKY; A A BATTS; L L BENNETT; C VCELLA; N B MCWILLIAMS; D F SMITH
Journal:  Am J Physiol       Date:  1963-10

2.  Ultrastructural study of alterations in beta cells of pancreatic islets from cyproheptadine-treated rats.

Authors:  D S Longnecker; J S Wold; L J Fischer
Journal:  Diabetes       Date:  1972-02       Impact factor: 9.461

3.  [Protein binding of some psychoactive drugs with a tricyclic ring system, as a function of their chemical constitution].

Authors:  H Glasser; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  [Mechanisof the appetite and body weight increasing effect of cyproheptadine. II. Changes in carbohydrate metabolism].

Authors:  D P Mertz; M Stelzer
Journal:  Klin Wochenschr       Date:  1969-11-15

5.  Studies of a simplified plasma insulin immunoassaay using cellulose powder.

Authors:  D S Zaharko; L V Beck
Journal:  Diabetes       Date:  1968-07       Impact factor: 9.461

6.  The effect of cyproheptadine on carbohydrate metabolism.

Authors:  A Drash; J Elliott; H Langs; A F Lavenstein; R E Cooke
Journal:  Clin Pharmacol Ther       Date:  1966 May-Jun       Impact factor: 6.875
  6 in total
  8 in total

1.  [Cyclic AMP and plasma renin activity in renal vein blood after amitryptiline, theophylline, furosemide and beta adrenergic blocking substances (author's transl)].

Authors:  J Zehner; D Klaus; F Klumpp; R Lemke
Journal:  Klin Wochenschr       Date:  1976-11-15

Review 2.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

3.  Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran).

Authors:  H G Joost; J Beckmann; S Holze; S Lenzen; W Poser; A Hasselblatt
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

4.  Subcellular B cell calcium and insulin secretion in vitro. Comparative ultracytochemical studies after glucose stimulation and cyproheptadine inhibition.

Authors:  G Bommer; H G Joost; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-09-07

5.  Mechanism by which cyproheptadine inhibits insulin secretion.

Authors:  P Donatsch; D A Lowe; B P Richardson; P Taylor
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

6.  Inhibition of insulin secretion from the perfused pancreas of the rat by pizotifen.

Authors:  H G Joost
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

7.  Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism.

Authors:  Philipp Gut; Bernat Baeza-Raja; Olov Andersson; Laura Hasenkamp; Joseph Hsiao; Daniel Hesselson; Katerina Akassoglou; Eric Verdin; Matthew D Hirschey; Didier Y R Stainier
Journal:  Nat Chem Biol       Date:  2012-12-02       Impact factor: 15.040

8.  Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice.

Authors:  Geng-Ruei Chang; Po-Hsun Hou; Wei-Cheng Yang; Chao-Min Wang; Pei-Shan Fan; Huei-Jyuan Liao; To-Pang Chen
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.